OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds

Dr Martens profits jump as turnaround gains grip

Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss.

7 Healthcare AI Stocks Under $50 With Huge Upside Potential

DOCS vs. HIMS: Which Stock Is the Better Value Option?

DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care

Doximity Earnings: Strong AI Signals, But Monetization Still Pending

Down 25.7% in 4 Weeks, Here's Why Doximity (DOCS) Looks Ripe for a Turnaround

Here Are Friday’s Top Wall Street Analyst Research Calls: Arista Networks, BWX Technologies, Cisco Systems, Danaher, Doximity, Estee Lauder, Illumina, Texas Roadhouse, Workday, and More

Doximity Stock Falls on Q4 Earnings Miss, Revenues Beat, Margins Down

Doximity Flags Pharma Ad Market Weakness

5 Things to Know Before the Stock Market Opens

These Analysts Slash Their Forecasts On Doximity After Q4 Results

Doximity plunges 24% on weak guidance, analysts slash PTs on increased AI spending

Doximity, Inc. (DOCS) Q4 2026 Earnings Call Transcript

Doximity Q4 Earnings Call Highlights

Doximity (DOCS) Lags Q4 Earnings Estimates

Doximity Partners with Aledade to Bring Clinical AI to Value-Based Care Settings

Doximity Announces Fourth Quarter and Fiscal Year 2026 Financial Results

Live: Can Doximity’s Q4 Earnings Tonight Spark a Rebound for the Beaten-Down Stock?

Doximity Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Breakfast News: Wix.com Pins Hopes on AI Tools

Hims & Hers Expands Digital Healthcare Platform via New Care Offerings

Breakfast News: Alphabet Surge Brings Bubble Fears

Insights Into Doximity (DOCS) Q4: Wall Street Projections for Key Metrics

Why the Market Dipped But Doximity (DOCS) Gained Today

Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?

Stock Market Today (LIVE): AMD Stocks Up as AI Demand Spikes; Peace Talks and Profits Lift Markets

3 Medical Info Systems Stocks Riding the GenAI Wave in a Tough Market

Doximity: Buy It As Mr. Market Is Selling It Cheap Under A Panic Attack

Doximity (DOCS) Outperforms Broader Market: What You Need to Know

Doximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026

Wall Street Analysts Think Doximity (DOCS) Is a Good Investment: Is It?

Doximity (DOCS) Falls More Steeply Than Broader Market: What Investors Need to Know

Harbor Active Small Cap ETF Q1 2026 Portfolio Review

Doximity (DOCS) Stock Dips While Market Gains: Key Facts

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Coinbase Global, Diamondback Energy, Deere, Doximity, Dutch Bros., Johnson & Johnson, Robinhood Markets, Verizon and More

Doximity (DOCS) Outperforms Broader Market: What You Need to Know

Critical Survey: Doximity (NYSE:DOCS) and Via Transportation (NYSE:VIA)

TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?

Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note

Doximity, Inc. (NYSE:DOCS) Given Consensus Recommendation of “Moderate Buy” by Brokerages

HIMS vs. DOCS: Which Digital Health Stock Offers Better Upside Now?

Doximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist

ArrowMark Colorado Holdings LLC Lowers Position in Doximity, Inc. $DOCS

Capital World Investors Increases Position in Doximity, Inc. $DOCS

Cresset Asset Management LLC Has $1.76 Million Stock Holdings in Doximity, Inc. $DOCS

Baron Health Care Fund Q4 2025 Contributors And Detractors

Doximity, Inc. (NYSE:DOCS) Receives Consensus Rating of “Moderate Buy” from Analysts

Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight.